Ustekinumab in Real-Life Practice: Experience in 116 Patients With Moderate-To-Severe Psoriasis

Acta Medica Portuguesa - Portugal
doi 10.20344/amp.10728
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Ordem dos Medicos

Related search

Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-To-Severe Psoriasis in the US Corrona Psoriasis Registry

Journal of Dermatological Treatment
Dermatology
2020English

The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis

Journal of Dermatological Treatment
Dermatology
2015English

Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)

British Journal of Dermatology
DermatologyMedicine
2014English

Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis

Archives of Dermatology
2004English

Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Effectiveness of Resuming Ustekinumab Therapy in Psoriasis Patients With Metabolic Disorders. Clinical Experience

Vestnik dermatologii i venerologii
2019English

Pss17 - Cost Per Responder Analysis of Brodalumab Compared With Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry

Journal of Dermatological Treatment
Dermatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy